Economic Observation Network Shanghai Pharmaceutical's controlling shareholder, Shangshi Group, and its concerted action parties have completed an increase in shareholding, with an increased shareholding ratio, demonstrating confidence in the company's development.

The controlling shareholder's increase in holdings has been completed:
Shangshi Group and its concerted action parties have completed an increase in shareholding, with a total shareholding of 40.456% This shows the supportive attitude of the controlling shareholder.

The above content is based on publicly available information and does not constitute investment advice.